NAGE Q2 2017 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-52.2% YoY

Gross Profit

$2M50.0% margin

Operating Income

-$3M-62.8% margin

Net Income

-$3M-65.5% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+25.2%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$400,000

Balance Sheet

Total Assets

$33M

Total Liabilities

$7M

Stockholders' Equity

$26M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$9M	-52.2%
Gross Profit	$2M	$4M	-48.9%
Operating Income	-$3M	$371,131	-814.0%
Net Income	-$3M	-$82,667	-3243.5%